Opioid consumption in Spain - the significance of a regulatory measure

Citation
Jg. Del Pozo et al., Opioid consumption in Spain - the significance of a regulatory measure, EUR J CL PH, 55(9), 1999, pp. 681-683
Citations number
14
Categorie Soggetti
Pharmacology,"Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
ISSN journal
00316970 → ACNP
Volume
55
Issue
9
Year of publication
1999
Pages
681 - 683
Database
ISI
SICI code
0031-6970(199911)55:9<681:OCIS-T>2.0.ZU;2-5
Abstract
Objective: To investigate the impact of new regulatory measures on opioid c onsumption in Spain during the period 1985-1998. Methods: A search in the ECOM (Especialidades Consume de Medicamentos) data base of the Ministry of Health was made for the 1985-1998 period. This data base contains information about drug preparations prescribed in primary car e in the National Health System in Spain. Results: Since 1985-1998, the overall opioid consumption has increased tenf old, from 94.7 DDD (defined daily dose) per million inhabitants per day to more than 1000 DDD. For the five drugs that require a special prescription form (morphine, methadone, pethidine, tilidine and fentanyl), the consumpti on has increased 13.5-fold. Conclusion: A huge increase in opioid consumption has occurred. In this inc rease, changes in supply and, to a lesser extent, regulatory measures have played an important role.